Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

SP ? 4.8mm WN, SLA? 10mm, Ti, Loxim: medical device reports filed with FDA

3,973 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

3,973
device reports naming the brand
0% of all MAUDE reports · about 575 a year
779
reports, 12 months to August 2026
713 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 3,973 reports that name the brand "SP ? 4.8mm WN, SLA? 10mm, Ti, Loxim" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

779 reports arrived in the 12 months to August 2026, close to the 713 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (67.1%), loss of osseointegration (30.4%) and difficult to insert (0.5%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

090180Sep 2021: 36Oct 2021: 34Nov 2021: 42Dec 2021: 222022Jan 2022: 33Feb 2022: 23Mar 2022: 42Apr 2022: 33May 2022: 23Jun 2022: 25Jul 2022: 34Aug 2022: 25Sep 2022: 18Oct 2022: 46Nov 2022: 62Dec 2022: 372023Jan 2023: 43Feb 2023: 31Mar 2023: 38Apr 2023: 51May 2023: 46Jun 2023: 73Jul 2023: 65Aug 2023: 85Sep 2023: 62Oct 2023: 50Nov 2023: 51Dec 2023: 662024Jan 2024: 53Feb 2024: 78Mar 2024: 37Apr 2024: 66May 2024: 64Jun 2024: 48Jul 2024: 68Aug 2024: 39Sep 2024: 37Oct 2024: 46Nov 2024: 68Dec 2024: 762025Jan 2025: 62Feb 2025: 30Mar 2025: 50Apr 2025: 42May 2025: 0Jun 2025: 180Jul 2025: 66Aug 2025: 56Sep 2025: 64Oct 2025: 97Nov 2025: 74Dec 2025: 762026Jan 2026: 62Feb 2026: 61Mar 2026: 47Apr 2026: 76May 2026: 55Jun 2026: 57Jul 2026: 59Aug 2026: 51

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03997972019: 22520192020: 33220202021: 40920212022: 40120222023: 66120232024: 68020242025: 79720252026: 4682026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%3,973
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report94.4%3,751
Voluntary report0%0
User facility report0%0
Distributor report5.6%222
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,66667.1%62.8%
Loss of osseointegration1,20830.4%22.4%
Difficult to insertthe device was hard to insert180.5%0.4%
Fracturea broken bone100.3%1.6%
Separation failure40.1%0.1%
Unintended movement20.1%0%
Unstable20.1%0%
Defective devicethe device was defective10%0%
Difficult to removethe device was hard to remove10%0%
Insufficient device problem information10%0.2%
Therapeutic or diagnostic output failure10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,00225.2%
Painpain, site not specified70317.7%
Tissue damage3709.3%
Inflammationinflammation1934.9%
Hemorrhage/blood loss/bleeding1674.2%
Swelling/ edema1403.5%
Abscessa collection of pus681.7%
Hyperresponsive to stimuli641.6%
Fistula350.9%
Hypersensitivity/allergic reaction320.8%
Failure of implant230.6%
Swellingswelling200.5%
Inadequate osseointegration140.4%
Numbnessnumbness120.3%
Sinus perforation100.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureSP ? 4.8mm WN, SLA? 10mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports3,9733,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer94.4%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about SP ? 4.8mm WN, SLA? 10mm, Ti, Loxim reports

How many FDA reports name SP ? 4.8mm WN, SLA? 10mm, Ti, Loxim?

3,973 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 779 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (67.1%), loss of osseointegration (30.4%), difficult to insert (0.5%), fracture (0.3%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (94.4%) and distributor reports (5.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that SP ? 4.8mm WN, SLA? 10mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.